Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$382000.0.

  • CV Sciences' Net Income towards Common Stockholders rose 1622.81% to -$382000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 4174.22%. This contributed to the annual value of -$2.4 million for FY2024, which is 17717.6% down from last year.
  • As of Q3 2025, CV Sciences' Net Income towards Common Stockholders stood at -$382000.0, which was up 1622.81% from -$261000.0 recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Net Income towards Common Stockholders registered a high of $5.7 million during Q1 2023, and its lowest value of -$8.9 million during Q4 2021.
  • In the last 5 years, CV Sciences' Net Income towards Common Stockholders had a median value of -$726000.0 in 2024 and averaged -$1.3 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 247750.0% in 2022, then skyrocketed by 47663.37% in 2023.
  • Quarter analysis of 5 years shows CV Sciences' Net Income towards Common Stockholders stood at -$8.9 million in 2021, then skyrocketed by 73.89% to -$2.3 million in 2022, then soared by 62.43% to -$869000.0 in 2023, then increased by 16.46% to -$726000.0 in 2024, then skyrocketed by 47.38% to -$382000.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$382000.0 for Q3 2025, versus -$261000.0 for Q2 2025 and -$109000.0 for Q1 2025.